{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:14:07Z","timestamp":1778336047313,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01387-z","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T03:15:54Z","timestamp":1778296554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NR1H4 downregulation facilitates abnormal cell proliferation contributing to IgA nephropathy pathogenesis, with potential clinical implications"],"prefix":"10.1007","volume":"39","author":[{"given":"Xian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1073-0953","authenticated-orcid":false,"given":"Changxi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"1387_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.916934","volume":"13","author":"J Qing","year":"2022","unstructured":"Qing J, Li C, Hu X, Song W, Tirichen H, Yaigoub H, et al. Differentiation of T helper 17 cells may mediate the abnormal humoral immunity in IgA nephropathy and inflammatory bowel disease based on shared genetic effects. Front Immunol. 2022;13:916934.","journal-title":"Front Immunol"},{"issue":"1","key":"1387_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/ki.2013.329","volume":"85","author":"EP McQuarrie","year":"2014","unstructured":"McQuarrie EP, Mackinnon B, McNeice V, Fox JG, Geddes CC. The incidence of biopsy-proven IgA nephropathy is associated with multiple socioeconomic deprivation. Kidney Int. 2014;85(1):198\u2013203.","journal-title":"Kidney Int"},{"issue":"3","key":"1387_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1523-1755.2004.00834.x","volume":"66","author":"P Simon","year":"2004","unstructured":"Simon P, Ramee MP, Boulahrouz R, Stanescu C, Charasse C, Ang KS, et al. Epidemiologic data of primary glomerular diseases in western France. Kidney Int. 2004;66(3):905\u20138.","journal-title":"Kidney Int"},{"issue":"2","key":"1387_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","volume":"361","author":"A Rajasekaran","year":"2021","unstructured":"Rajasekaran A, Julian BA, Rizk DV. IgA nephropathy: an interesting autoimmune kidney disease. Am J Med Sci. 2021;361(2):176\u201394.","journal-title":"Am J Med Sci"},{"issue":"1","key":"1387_CR5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12882-021-02606-5","volume":"22","author":"SY Wei","year":"2021","unstructured":"Wei SY, Guo S, Feng B, Ning SW, Du XY. Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis. BMC Nephrol. 2021;22(1):392.","journal-title":"BMC Nephrol"},{"issue":"1","key":"1387_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/0886022X.2021.2019589","volume":"44","author":"K Zhang","year":"2022","unstructured":"Zhang K, Tang L, Jiang SS, Wang YF, Meng Y, Wang MD, et al. Is hyperuricemia an independent prognostic factor for IgA nephropathy: a systematic review and meta-analysis of observational cohort studies. Ren Fail. 2022;44(1):70\u201380.","journal-title":"Ren Fail"},{"issue":"3","key":"1387_CR7","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1523-1755.2004.00837.x","volume":"66","author":"LS Li","year":"2004","unstructured":"Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004;66(3):920\u20133.","journal-title":"Kidney Int"},{"issue":"2","key":"1387_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5414\/CNP63061","volume":"63","author":"CS Lim","year":"2005","unstructured":"Lim CS, Kim YS, Chae DW, Ahn C, Han JS, Kim S, et al. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. Clin Nephrol. 2005;63(2):61\u20137.","journal-title":"Clin Nephrol"},{"key":"1387_CR9","doi-asserted-by":"publisher","first-page":"8794013","DOI":"10.1155\/2019\/8794013","volume":"2019","author":"W Qian","year":"2019","unstructured":"Qian W, Xiaoyi W, Zi Y. Screening and bioinformatics analysis of IgA nephropathy gene based on GEO databases. Biomed Res Int. 2019;2019:8794013.","journal-title":"Biomed Res Int"},{"issue":"8","key":"1387_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/jcp.2005.027797","volume":"59","author":"M Colovic","year":"2006","unstructured":"Colovic M, Jurisic V, Jankovic G, Jovanovic D, Nikolic LJ, Dimitrijevic J. Interferon alpha sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia: case report and review of literature. J Clin Pathol. 2006;59(8):879\u201381.","journal-title":"J Clin Pathol"},{"issue":"4","key":"1387_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.kint.2018.02.030","volume":"94","author":"MK Saha","year":"2018","unstructured":"Saha MK, Julian BA, Novak J, Rizk DV. Secondary IgA nephropathy. Kidney Int. 2018;94(4):674\u201381.","journal-title":"Kidney Int"},{"key":"1387_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010189","author":"F Sallustio","year":"2019","unstructured":"Sallustio F, Curci C, Di Leo V, Gallone A, Pesce F, Gesualdo L. A new vision of IgA nephropathy: the missing link. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms21010189.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1387_CR13","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/ckj\/sfaa204","volume":"14","author":"S Park","year":"2021","unstructured":"Park S, Baek CH, Park SK, Kang HG, Han SH, Ryu DR, et al. Increasing prescription of renin-angiotensin-aldosterone system blockers associated with improved kidney prognosis in Korean IgA nephropathy patients. Clin Kidney J. 2021;14(6):1673\u201380.","journal-title":"Clin Kidney J"},{"issue":"1","key":"1387_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13073-024-01356-x","volume":"16","author":"S Si","year":"2024","unstructured":"Si S, Liu H, Xu L, Zhan S. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. Genome Med. 2024;16(1):84.","journal-title":"Genome Med"},{"issue":"1","key":"1387_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00005-023-00677-w","volume":"71","author":"K Mucha","year":"2023","unstructured":"Mucha K, Pac M, Paczek L. Omics are getting us closer to understanding IgA nephropathy. Arch Immunol Ther Exp (Warsz). 2023;71(1):12.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"Pt A","key":"1387_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113087","volume":"142","author":"J Li","year":"2024","unstructured":"Li J, Liu H, Hu X, Zhang S, Yu Q, Kuang G, et al. NR1H4 ameliorates Parkinson\u2019s disease via inhibiting astrocyte activation and neuroinflammation in a CEBPbeta\/NF-kappaB dependent manner. Int Immunopharmacol. 2024;142(Pt A):113087.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"1387_CR17","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","volume":"36","author":"P Horn","year":"2024","unstructured":"Horn P, Tacke F. Metabolic reprogramming in liver fibrosis. Cell Metab. 2024;36(7):1439\u201355.","journal-title":"Cell Metab"},{"issue":"5","key":"1387_CR18","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41401-021-00849-4","volume":"43","author":"SY Tian","year":"2022","unstructured":"Tian SY, Chen SM, Pan CX, Li Y. FXR: structures, biology, and drug development for NASH and fibrosis diseases. Acta Pharmacol Sin. 2022;43(5):1120\u201332.","journal-title":"Acta Pharmacol Sin"},{"key":"1387_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106101","volume":"177","author":"S Guo","year":"2022","unstructured":"Guo S, Peng Y, Lou Y, Cao L, Liu J, Lin N, et al. Downregulation of the farnesoid X receptor promotes colorectal tumorigenesis by facilitating enterotoxigenic Bacteroides fragilis colonization. Pharmacol Res. 2022;177:106101.","journal-title":"Pharmacol Res"},{"key":"1387_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101841","volume":"79","author":"DQ Sun","year":"2024","unstructured":"Sun DQ, Yuan F, Fu MZ, Zhong MY, Zhang SL, Lu Y, et al. Farnesoid X receptor activation protects against renal fibrosis via modulation of beta-catenin signaling. Molecular metabolism. 2024;79:101841.","journal-title":"Molecular metabolism"},{"issue":"9","key":"1387_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1159\/000538038","volume":"148","author":"J Yang","year":"2024","unstructured":"Yang J, Pontoglio M, Terzi F. Bile acids and farnesoid X receptor in renal pathophysiology. Nephron. 2024;148(9):618\u201330.","journal-title":"Nephron"},{"issue":"7","key":"1387_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1387_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"key":"1387_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1146849","volume":"11","author":"R Liu","year":"2023","unstructured":"Liu R, Peng Y, Du W, Wu Y, Zhang W, Hu C, et al. BMI1 fine-tunes gene repression and activation to safeguard undifferentiated spermatogonia fate. Front Cell Dev Biol. 2023;11:1146849.","journal-title":"Front Cell Dev Biol"},{"issue":"D1","key":"1387_CR25","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"1387_CR26","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"4","key":"1387_CR27","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu G, Wang LG, Yan GR, He QY. DOSE: an R\/bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics. 2015;31(4):608\u20139.","journal-title":"Bioinformatics"},{"issue":"5","key":"1387_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"1","key":"1387_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.","journal-title":"Genome Biol"},{"issue":"9","key":"1387_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13278","volume":"55","author":"L Zhao","year":"2022","unstructured":"Zhao L, Lan Z, Peng L, Wan L, Liu D, Tan X, et al. Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9\/p38 MAPK pathway. Cell Prolif. 2022;55(9):e13278.","journal-title":"Cell Prolif"},{"issue":"5","key":"1387_CR31","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1080\/09273948.2022.2081862","volume":"31","author":"Y Gao","year":"2023","unstructured":"Gao Y, Liu L, Zhang Z, Qin C, Yang B, Ke Y. TYRP1 protects against the apoptosis and oxidative stress of retinal ganglion cells by binding to PMEL. Ocul Immunol Inflamm. 2023;31(5):1024\u201334.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"1387_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12012-024-09937-3","volume":"25","author":"L Wu","year":"2025","unstructured":"Wu L, Yang B, Sun Y, Fan G, Ma L, Ma Y, et al. Isoprenaline inhibits histone demethylase LSD1 to induce cardiac hypertrophy. Cardiovasc Toxicol. 2025;25(1):34\u201347.","journal-title":"Cardiovasc Toxicol"},{"issue":"9","key":"1387_CR33","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1089\/dna.2021.0095","volume":"40","author":"Q Fei","year":"2021","unstructured":"Fei Q, Qiu M, Fan G, Zhang B, Wang Q, Zhang S, et al. Downregulation of Hotair or LSD1 impaired heart regeneration in the neonatal mouse. DNA Cell Biol. 2021;40(9):1177\u201384.","journal-title":"DNA Cell Biol"},{"issue":"50","key":"1387_CR34","doi-asserted-by":"publisher","first-page":"15787","DOI":"10.1021\/acs.jafc.2c06297","volume":"70","author":"P Wang","year":"2022","unstructured":"Wang P, Zhang X, Zheng X, Gao J, Shang M, Xu J, et al. Folic acid protects against hyperuricemia in C57BL\/6J mice via ameliorating gut-kidney axis dysfunction. J Agric Food Chem. 2022;70(50):15787\u2013803.","journal-title":"J Agric Food Chem"},{"issue":"3","key":"1387_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00232-010-9309-7","volume":"239","author":"V Jurisic","year":"2011","unstructured":"Jurisic V, Srdic-Rajic T, Konjevic G, Bogdanovic G, Colic M. TNF-alpha induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells. J Membr Biol. 2011;239(3):115\u201322.","journal-title":"J Membr Biol"},{"issue":"1","key":"1387_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12291-023-01161-0","volume":"40","author":"N Radenkovic","year":"2025","unstructured":"Radenkovic N, Milutinovic M, Nikodijevic D, Jovankic J, Jurisic V. Sample preparation of adherent cell lines for flow cytometry: protocol optimization-our experience with SW-480 colorectal cancer cell line. Indian J Clin Biochem. 2025;40(1):74\u20139.","journal-title":"Indian J Clin Biochem"},{"issue":"6","key":"1387_CR37","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1172\/JCI74475","volume":"124","author":"K Kiryluk","year":"2014","unstructured":"Kiryluk K, Novak J. The genetics and immunobiology of IgA nephropathy. J Clin Invest. 2014;124(6):2325\u201332.","journal-title":"J Clin Invest"},{"key":"1387_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"1387_CR39","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00467-017-3699-z","volume":"33","author":"SC Yeo","year":"2018","unstructured":"Yeo SC, Cheung CK, Barratt J. New insights into the pathogenesis of IgA nephropathy. Pediatr Nephrol. 2018;33(5):763\u201377.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"1387_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","volume":"5","author":"L Ding","year":"2015","unstructured":"Ding L, Yang L, Wang Z, Huang W. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B. 2015;5(2):135\u201344.","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"1387_CR41","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.bbadis.2010.11.011","volume":"1812","author":"JK Kemper","year":"2011","unstructured":"Kemper JK. Regulation of FXR transcriptional activity in health and disease: emerging roles of FXR cofactors and post-translational modifications. Biochim Biophys Acta. 2011;1812(8):842\u201350.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1387_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","volume":"89","author":"P Lefebvre","year":"2009","unstructured":"Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev. 2009;89(1):147\u201391.","journal-title":"Physiol Rev"},{"issue":"10","key":"1387_CR43","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2165\/00003495-200767100-00001","volume":"67","author":"B Staels","year":"2007","unstructured":"Staels B, Kuipers F. Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs. 2007;67(10):1383\u201392.","journal-title":"Drugs"},{"issue":"6","key":"1387_CR44","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1073\/pnas.1323977111","volume":"111","author":"X Zhang","year":"2014","unstructured":"Zhang X, Huang S, Gao M, Liu J, Jia X, Han Q, et al. Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice. Proc Natl Acad Sci USA. 2014;111(6):2277\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1387_CR45","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1186\/s12887-025-05980-3","volume":"25","author":"R Belhadj","year":"2025","unstructured":"Belhadj R, Maaloul I, Besghaier W, Kolsi R, Sabaouni N, Broly F, et al. Progressive familial intrahepatic cholestasis type 5 due to a novel mutation in the NR1H4 gene. BMC Pediatr. 2025;25(1):870.","journal-title":"BMC Pediatr"},{"issue":"1","key":"1387_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12920-022-01240-w","volume":"15","author":"H Lai","year":"2022","unstructured":"Lai H, Liu X, Xin S, Zheng J, Liu H, Ouyang Y, et al. Identification of two novel pathogenic variants of the NR1H4 gene in intrahepatic cholestasis of pregnancy patients. BMC Med Genomics. 2022;15(1):90.","journal-title":"BMC Med Genomics"},{"issue":"2","key":"1387_CR47","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s12276-023-00932-2","volume":"55","author":"DH Kim","year":"2023","unstructured":"Kim DH, Park JS, Choi HI, Kim CS, Bae EH, Ma SK, et al. The role of the Farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases. Exp Mol Med. 2023;55(2):304\u201312.","journal-title":"Exp Mol Med"},{"issue":"4","key":"1387_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41419-021-03620-z","volume":"12","author":"DH Kim","year":"2021","unstructured":"Kim DH, Park JS, Choi HI, Kim CS, Bae EH, Ma SK, et al. The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD. Cell Death Dis. 2021;12(4):320.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1387_CR49","doi-asserted-by":"publisher","first-page":"9815","DOI":"10.1038\/s41598-017-10168-6","volume":"7","author":"Z Gai","year":"2017","unstructured":"Gai Z, Chu L, Xu Z, Song X, Sun D, Kullak-Ublick GA. Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage. Sci Rep. 2017;7(1):9815.","journal-title":"Sci Rep"},{"issue":"11","key":"1387_CR50","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.2337\/db10-0019","volume":"59","author":"XX Wang","year":"2010","unstructured":"Wang XX, Jiang T, Shen Y, Caldas Y, Miyazaki-Anzai S, Santamaria H, et al. Diabetic nephropathy is accelerated by Farnesoid X receptor deficiency and inhibited by Farnesoid X receptor activation in a type 1 diabetes model. Diabetes. 2010;59(11):2916\u201327.","journal-title":"Diabetes"},{"issue":"4","key":"1387_CR51","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1021\/acsmedchemlett.8b00108","volume":"9","author":"AF Abdel-Magid","year":"2018","unstructured":"Abdel-Magid AF. Therapeutic potential of FXR agonists in the treatment of multiple diseases. ACS Med Chem Lett. 2018;9(4):294\u20135.","journal-title":"ACS Med Chem Lett"},{"key":"1387_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012259","author":"S Liu","year":"2025","unstructured":"Liu S, Liang Z, Zhu L, Zheng Y, Yu H, Ye S, et al. FXR-mediated antigen-specific CD8(+) T cell enhances antitumor immunity in intrahepatic cholangiocarcinoma. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2025-012259.","journal-title":"J Immunother Cancer"},{"key":"1387_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.646650","volume":"12","author":"M Yang","year":"2021","unstructured":"Yang M, Liu JW, Zhang YT, Wu G. The role of renal macrophage, AIM, and TGF-beta1 expression in renal fibrosis progression in IgAN patients. Front Immunol. 2021;12:646650.","journal-title":"Front Immunol"},{"key":"1387_CR54","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clim.2019.05.005","volume":"205","author":"W Hu","year":"2019","unstructured":"Hu W, Lin J, Lian X, Yu F, Liu W, Wu Y, et al. M2a and M2b macrophages predominate in kidney tissues and M2 subpopulations were associated with the severity of disease of IgAN patients. Clin Immunol. 2019;205:8\u201315.","journal-title":"Clin Immunol"},{"key":"1387_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.838863","volume":"13","author":"B Li","year":"2022","unstructured":"Li B, Li S, Fan Y, Diao H, Ye S, Peng H, et al. Computational analysis reveals the characteristics of immune cells in glomerular and tubulointerstitial compartments in IgA nephropathy patients. Front Genet. 2022;13:838863.","journal-title":"Front Genet"},{"issue":"3","key":"1387_CR56","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1046\/j.1523-1755.2003.00183.x","volume":"64","author":"SE Jones","year":"2003","unstructured":"Jones SE, Kelly DJ, Cox AJ, Zhang Y, Gow RM, Gilbert RE. Mast cell infiltration and chemokine expression in progressive renal disease. Kidney Int. 2003;64(3):906\u201313.","journal-title":"Kidney Int"},{"issue":"3","key":"1387_CR57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1155\/2008\/725408","volume":"24","author":"GE Silva","year":"2008","unstructured":"Silva GE, Costa RS, Ravinal RC, dos Reis MA, Dantas M, Coimbra TM. Mast cells, TGF-beta1 and alpha-SMA expression in IgA nephropathy. Dis Markers. 2008;24(3):181\u201390.","journal-title":"Dis Markers"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01387-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01387-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01387-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:02:55Z","timestamp":1778335375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01387-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["1387"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01387-z","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our study was approved by the Ethics Committee of Tianjin Fifth Central Hospital, in accordance with the Declaration of Helsinki (ethic code: WZX-EC-KY2024002).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"74"}}